251 related articles for article (PubMed ID: 35748393)
1. Alpha-2 Adrenoreceptor Antagonist Yohimbine Potentiates Consolidation of Conditioned Fear.
Sperl MFJ; Panitz C; Skoluda N; Nater UM; Pizzagalli DA; Hermann C; Mueller EM
Int J Neuropsychopharmacol; 2022 Sep; 25(9):759-773. PubMed ID: 35748393
[TBL] [Abstract][Full Text] [Related]
2. Representational similarity analysis offers a preview of the noradrenergic modulation of long-term fear memory at the time of encoding.
Visser RM; Kunze AE; Westhoff B; Scholte HS; Kindt M
Psychoneuroendocrinology; 2015 May; 55():8-20. PubMed ID: 25705798
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of the noradrenergic system during memory formation impairs extinction learning but not the disruption of reconsolidation.
Soeter M; Kindt M
Neuropsychopharmacology; 2012 Apr; 37(5):1204-15. PubMed ID: 22169947
[TBL] [Abstract][Full Text] [Related]
4. Enhanced noradrenergic activity by yohimbine and differential fear conditioning in patients with major depression with and without adverse childhood experiences.
Kuehl LK; Deuter CE; Hellmann-Regen J; Kaczmarczyk M; Otte C; Wingenfeld K
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109751. PubMed ID: 31446157
[TBL] [Abstract][Full Text] [Related]
5. Noradrenergic enhancement of associative fear memory in humans.
Soeter M; Kindt M
Neurobiol Learn Mem; 2011 Sep; 96(2):263-71. PubMed ID: 21624479
[TBL] [Abstract][Full Text] [Related]
6. Does yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trial.
Meyerbroeker K; Powers MB; van Stegeren A; Emmelkamp PM
Psychother Psychosom; 2012; 81(1):29-37. PubMed ID: 22116378
[TBL] [Abstract][Full Text] [Related]
7. Dopamine D2 receptors in the expression and extinction of contextual and cued conditioned fear in rats.
de Vita VM; Zapparoli HR; Reimer AE; Brandão ML; de Oliveira AR
Exp Brain Res; 2021 Jun; 239(6):1963-1974. PubMed ID: 33885919
[TBL] [Abstract][Full Text] [Related]
8. Adrenergic transmission facilitates extinction of conditional fear in mice.
Cain CK; Blouin AM; Barad M
Learn Mem; 2004; 11(2):179-87. PubMed ID: 15054133
[TBL] [Abstract][Full Text] [Related]
9. Yohimbine impairs extinction of cocaine-conditioned place preference in an alpha2-adrenergic receptor independent process.
Davis AR; Shields AD; Brigman JL; Norcross M; McElligott ZA; Holmes A; Winder DG
Learn Mem; 2008 Sep; 15(9):667-76. PubMed ID: 18772254
[TBL] [Abstract][Full Text] [Related]
10. The effect of yohimbine on the extinction of conditioned fear: a role for context.
Morris RW; Bouton ME
Behav Neurosci; 2007 Jun; 121(3):501-14. PubMed ID: 17592941
[TBL] [Abstract][Full Text] [Related]
11. Modulation of cannabinoid signaling by amygdala α2-adrenergic system in fear conditioning.
Nasehi M; Zamanparvar M; Ebrahimi-Ghiri M; Zarrindast MR
Behav Brain Res; 2016 Mar; 300():114-22. PubMed ID: 26698395
[TBL] [Abstract][Full Text] [Related]
12. Initial evidence for pharmacological modulation of observational threat learning by the GABAergic, but not the noradrenergic system in humans.
Esser R; Fuss J; Haaker J
Behav Res Ther; 2020 Jun; 129():103605. PubMed ID: 32259695
[TBL] [Abstract][Full Text] [Related]
13. Enhanced noradrenergic activity potentiates fear memory consolidation and reconsolidation by differentially recruiting α1- and β-adrenergic receptors.
Gazarini L; Stern CA; Carobrez AP; Bertoglio LJ
Learn Mem; 2013 Mar; 20(4):210-9. PubMed ID: 23512937
[TBL] [Abstract][Full Text] [Related]
14. Yohimbine depresses excitatory transmission in BNST and impairs extinction of cocaine place preference through orexin-dependent, norepinephrine-independent processes.
Conrad KL; Davis AR; Silberman Y; Sheffler DJ; Shields AD; Saleh SA; Sen N; Matthies HJ; Javitch JA; Lindsley CW; Winder DG
Neuropsychopharmacology; 2012 Sep; 37(10):2253-66. PubMed ID: 22617356
[TBL] [Abstract][Full Text] [Related]
15. Effects of repeated yohimbine administration on reinstatement of palatable food seeking: involvement of dopamine D
Ball KT; Miller L; Sullivan C; Wells A; Best O; Cavanaugh B; Copus T; Corrigan N; Hawkins S; Kobbe K; Schoener A; Steiger J; Vieweg L
Addict Biol; 2016 Nov; 21(6):1140-1150. PubMed ID: 26223161
[TBL] [Abstract][Full Text] [Related]
16. Learning pain-related fear: neural mechanisms mediating rapid differential conditioning, extinction and reinstatement processes in human visceral pain.
Gramsch C; Kattoor J; Icenhour A; Forsting M; Schedlowski M; Gizewski ER; Elsenbruch S
Neurobiol Learn Mem; 2014 Dec; 116():36-45. PubMed ID: 25128878
[TBL] [Abstract][Full Text] [Related]
17. PTSD-like memory generated through enhanced noradrenergic activity is mitigated by a dual step pharmacological intervention targeting its reconsolidation.
Gazarini L; Stern CA; Piornedo RR; Takahashi RN; Bertoglio LJ
Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539509
[TBL] [Abstract][Full Text] [Related]
18. (Lack of) Effects of noradrenergic stimulation on human working memory performance.
Wanke N; Müller JC; Wiedemann K; Schwabe L
Psychopharmacology (Berl); 2020 Oct; 237(10):3033-3046. PubMed ID: 32583013
[TBL] [Abstract][Full Text] [Related]
19. Effects of noradrenergic stimulation on memory in patients with major depressive disorder.
Wingenfeld K; Kuffel A; Uhlmann C; Terfehr K; Schreiner J; Kuehl LK; Otte C; Löwe B; Spitzer C
Stress; 2013 Mar; 16(2):191-201. PubMed ID: 22746337
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoids, Noradrenergic Arousal, and the Control of Memory Retrieval.
Zerbes G; Kausche FM; Müller JC; Wiedemann K; Schwabe L
J Cogn Neurosci; 2019 Feb; 31(2):288-298. PubMed ID: 30407136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
